Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared on X:
“A marvelous kick-off here in IOHK 2026 with Tony Mok on stage and Pietro Veronesi delivering an excellent presentation on the impact of China drug development on Global market highlighting the new model:
- Preclinical/early phase in China: cheep, fast, proof of concept;
- International collaboration for Global Phase 3: license in China based on local Ph3 and confirmatory Ph3 for the global population.
Landscape is changing fast and the need to reduce prices is more urgent than ever!”
You can also read: Herbert Loong: Insights Shared by Tony Mok on the Global Impact of Cancer Drug Development in China
